

CSAR / Research4Babies at PAS 2026 – Boston 🇺🇸
See you at Pediatric Academic Societies (PAS) 2026 in Boston! The CSAR / Research4Babies team is on the way to Pediatric Academic Societies Meeting 2026 in Boston, and we are excited to share a strong lineup of presentations, sessions, and posters. If you are attending PAS - come find us! 🔬 Featured Sessions PAS Ticketed Event Neonatal Resuscitation 2026: Beyond the Basics 🗓 Friday, April 24, 2026 ⏰ 8:00 AM – 1:35 PM ET📍 Convention Center: 109 West Georg Schmölzer will be
Apr 232 min read


What a Week for CSAR / Research4Babies 🚀
Some weeks stand out—and this was definitely one of them for the CSAR / Research4Babies team. 🧪 HiLo Trial milestones We were delighted to welcome the team at Université de Sherbrooke as they officially began recruitment for the HiLo Trial. Expanding our network of engaged and committed sites is key to the success of this important study. At the same time, we reached an incredible milestone:1,150 out of 1,200 patients recruited 🎉 This brings us very close to completing one
Apr 222 min read


The HiLo-Trial has enrolled 1️⃣1️⃣5️⃣0️⃣ babies Congratulations and Thank you!
We would like to congratulate all sites for recruiting 1150 of 1200 patients. Congratulations, what an achievement! Thank you to everyone involved and being part of the HiLo-journey and thanks to all the parents who have consented for their babies to be part of this trial. Oxygen is a vital element in the care of preterm infants and has been given more often than any other drug over the past 80 years. Despite this, we know very little about how much or how little oxygen is sa
Apr 202 min read


Welcome to the team at Université de Sherbrooke for starting recruitment for the HiLo-Trial
Oxygen is a vital element in the care of preterm infants and has been given more often than any other drug over the past 80 years. Despite this, we know very little about how much or how little oxygen is safe particularly at birth. Preterm birth, or birth before 37 weeks’ gestation, is occurring in 8% of pregnancies in Canada. Preterm birth is associated with many health complications, particularly when the birth happens before 29 weeks’ gestation. At this gestational age, t
Apr 202 min read


Chest Compression superimposed with Sustained Inflation – Translating preclinical findings into a neonatal clinical trial
From bench to bedside: translating physiology into clinical trials Cardiopulmonary resuscitation (CPR) at birth remains one of the most critical—and challenging—situations in neonatal care. While only a small proportion of newborns require CPR, the outcomes are sobering: mortality remains high, and survivors often face significant neurological injury. This blog highlights an important journey in neonatal resuscitation research— the development and translation of chest compres
Apr 173 min read


Congratulations to the team at Centre Hospitalier Universitaire de Québec for completing recruitment for the HiLo-Trial
Oxygen is a vital element in the care of preterm infants and has been given more often than any other drug over the past 80 years. Despite this, we know very little about how much or how little oxygen is safe particularly at birth. Preterm birth, or birth before 37 weeks’ gestation, is occurring in 8% of pregnancies in Canada. Preterm birth is associated with many health complications, particularly when the birth happens before 29 weeks’ gestation. At this gestational age, t
Apr 92 min read


Celebrating a Major Milestone: Marwa Ramsie Passes Her PhD Candidacy Exam 🎓
I am delighted to share some fantastic news from our team at CSAR: Marwa Ramsie has successfully passed her PhD Candidacy Exam —a major milestone that marks her transition to independent doctoral research. \A focused and impactful PhD program Marwa’s PhD work centers on vasopressin as a potential alternative to epinephrine during neonatal cardiopulmonary resuscitation (CPR) . Her research addresses a critical gap in neonatal resuscitation science, combining rigorous physiolo
Feb 22 min read


Congratulations to the team at Ottawa Hospital and CHEO for completing recruitment for the HiLo-Trial
Oxygen is a vital element in the care of preterm infants and has been given more often than any other drug over the past 80 years. Despite this, we know very little about how much or how little oxygen is safe particularly at birth. Preterm birth, or birth before 37 weeks’ gestation, is occurring in 8% of pregnancies in Canada. Preterm birth is associated with many health complications, particularly when the birth happens before 29 weeks’ gestation. At this gestational age, t
Jan 302 min read


Study Protocol SpotlightThe VOLT Trial: Volume-Targeted Mask Ventilation versus Pressure Ventilation in Preterm Infants
Providing effective and gentle respiratory support in the first minutes after birth is one of the most critical—and challenging—tasks in neonatal care. The VOLT trial (Volume-Targeted mask ventilation versus pressure ventilation in preterm infants) was designed to address a fundamental gap in delivery room practice: how to reliably deliver safe tidal volumes during positive pressure ventilation (PPV) immediately after birth. Why does this matter? When preterm infants fail to
Jan 293 min read


Educational Tour through Pakistan – Part 6
Reflections, gratitude, and lasting impressions The educational tour through Pakistan was an intense, rewarding, and deeply meaningful experience. Over several days, I had the privilege of engaging with clinicians, nurses, educators, and leaders across multiple institutions in Karachi and Lahore, all united by a shared commitment to improving outcomes for newborn infants. Education, exchange, and collaboration The program focused on neonatal resuscitation and respiratory sup
Jan 252 min read















